OCGN · NASDAQ
Ocugen (OCGN) Stock Price & Fundamentals
Ocugen (OCGN) closed at $447.05 on Oct 9, 2026, down 0.27% from the previous close of $448.27.
Share price, past year
1Y +14.60%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $447.05 |
| Sep 30, 2026 | $448.08 |
| Aug 31, 2026 | $431.12 |
| Jul 31, 2026 | $442.21 |
| Jun 30, 2026 | $458.38 |
| May 29, 2026 | $447.12 |
| Apr 30, 2026 | $451.51 |
| Mar 31, 2026 | $413.86 |
| Feb 27, 2026 | $394.05 |
| Jan 30, 2026 | $362.41 |
| Dec 31, 2025 | $364.63 |
| Nov 28, 2025 | $366.31 |
| Oct 31, 2025 | $379.35 |
Key statistics
- Market cap
- $151.57B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$81.81M
- Shares outstanding
- 339M
- Dividend yield
- —
- 52-week range
- $359.40 – $467.28
Ocugen's market cap is $151.57B, based on a share price of $447.05 and 339M shares outstanding as of Jun 30, 2026.
Financials
Ocugen reported revenue of $4.41M for fiscal 2025, up 8.83% from fiscal 2024.
Ocugen reported a net loss of $67.85M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $4.41M | +8.8% | −$67.85M | −1,537.4% | — | −$57.15M |
| FY2024ended Dec 31, 2024 | $4.06M | −32.8% | −$54.05M | −1,333.0% | — | −$45.53M |
| FY2023ended Dec 31, 2023 | $6.04M | +142.6% | −$63.08M | −1,045.0% | −$0.26 | −$72.53M |
| FY2022ended Dec 31, 2022 | $2.49M | — | −$86.80M | −3,488.9% | −$0.40 | −$64.54M |
| FY2021ended Dec 31, 2021 | $0.00 | −100.0% | −$58.37M | — | −$0.30 | −$48.88M |
| FY2020ended Dec 31, 2020 | $43.00K | — | −$21.82M | −50,748.8% | −$0.31 | −$15.02M |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$20.24M | — | −$1.46 | −$16.92M |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$18.22M | — | −$0.79 | −$11.71M |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$26.41M | — | −$0.99 | −$23.30M |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$16.21M | — | −$2.18 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.49M | −$24.88M | −$0.07 |
| Q1 FY2026ended Mar 31, 2026 | $1.53M | −$19.18M | −$0.06 |
| Q3 FY2025ended Sep 30, 2025 | $1.75M | −$20.05M | — |
| Q2 FY2025ended Jun 30, 2025 | $1.37M | −$14.74M | −$0.05 |
| Q1 FY2025ended Mar 31, 2025 | $1.48M | −$15.35M | −$0.05 |
| Q4 FY2024ended Dec 31, 2024 | $764.00K | −$13.88M | — |
| Q3 FY2024ended Sep 30, 2024 | $1.14M | −$12.97M | — |
| Q2 FY2024ended Jun 30, 2024 | $1.14M | — | −$0.04 |
Company profile
- Name
- Ocugen, Inc.
- Ticker
- OCGN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 11 Great Valley Parkway, Malvern, PA 19355
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001372299
Recent SEC filings
- Oct 6, 2026
- Sep 23, 2026
- Sep 8, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 13, 2026
- Jun 11, 2026
- Jun 3, 2026
Frequently asked questions
What is Ocugen's stock price?
Ocugen (OCGN) closed at $447.05 on Oct 9, 2026, down 0.27% from the previous close of $448.27.
What is Ocugen's market cap?
Ocugen's market cap is $151.57B, based on a share price of $447.05 and 339M shares outstanding as of Jun 30, 2026.
How much revenue does Ocugen make?
Ocugen reported revenue of $4.41M for fiscal 2025, up 8.83% from fiscal 2024.
Does Ocugen pay a dividend?
Ocugen's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Ocugen, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures